Skip to main navigation Skip to search Skip to main content

Cost-utility of tofacitinib for the treatment of severe to moderate rheumatoid arthritis in Portugal

Research output: Contribution to journal › Meeting abstract › peer-review

Original languageEnglish
Article numberPSY5
Pages (from-to)S901-S901
Number of pages1
JournalValue in Health
Volume22
Issue numberS3
Publication statusPublished - Nov 2019
EventISPOR Europe 2019 - Bella Center Copenhagen, Copenhagen, Denmark
Duration: 2 Jan 2019 → 6 Nov 2019

Cite this